Synthetic cannabinoids in "Spice" products were stronger than natural cannabis and showed signs of causing addiction
A review found that synthetic cannabinoids in "Spice" herbal products bound to cannabinoid receptors more potently than natural cannabis and were associated with addiction and withdrawal symptoms.
Quick Facts
What This Study Found
The review examined the emerging problem of synthetic cannabinoids sold as "Spice" herbal products. Key findings included:
Synthetic cannabinoids in these products bound to cannabinoid receptors more strongly than natural cannabis. Chronic abuse was linked to signs of addiction and withdrawal symptoms similar to those observed with cannabis.
The products were marketed as "herbal highs" despite containing entirely synthetic compounds. It remained unclear where or how production took place, but manufacturers were knowingly risking consumer health.
Major challenges included difficulty identifying the specific synthetic compounds in products, lack of reference standards for laboratory testing, and the speed at which new compounds appeared on the market. Several European countries, the US, and Canada had begun banning specific synthetic cannabinoids.
Key Numbers
Synthetic cannabinoids described as stronger than natural cannabis at cannabinoid receptors. Multiple countries in Europe plus the US and Canada had banned some compounds by 2010.
How They Did This
Narrative review searching multiple literature databases for information on psychoactive properties, safety profiles, clinical data, and detection problems related to synthetic cannabinoids in "Spice" products.
Why This Research Matters
The review served as an early warning about a rapidly growing public health problem that would later produce numerous emergency department visits and deaths from novel synthetic cannabinoid products.
The Bigger Picture
"Spice" products represented a new category of "designer drugs" that exploited gaps in drug legislation, with new synthetic variants appearing faster than regulators could ban them.
What This Study Doesn't Tell Us
Limited clinical and safety data available at the time. The rapidly evolving nature of the products meant that information was quickly outdated. Most evidence was from case reports rather than systematic research.
Questions This Raises
- ?How do synthetic cannabinoids differ from natural cannabis in terms of health risks?
- ?Can regulatory frameworks keep pace with novel synthetic compound development?
Trust & Context
- Key Stat:
- Synthetic cannabinoids bind to receptors more strongly than natural cannabis
- Evidence Grade:
- Early review of an emerging public health concern with limited systematic data available.
- Study Age:
- Published in 2010. The synthetic cannabinoid problem has grown dramatically since, with many more compounds and associated harms documented.
- Original Title:
- Spice drugs as a new trend: mode of action, identification and legislation.
- Published In:
- Toxicology letters, 197(3), 157-62 (2010)
- Authors:
- Vardakou, I, Pistos, C, Spiliopoulou, Ch
- Database ID:
- RTHC-00458
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What are "Spice" products?
"Spice" products are herbal mixtures sprayed with synthetic cannabinoids, chemicals designed to activate the same brain receptors as THC. They are often marketed as "legal" alternatives to cannabis despite being more potent and potentially more dangerous.
Are synthetic cannabinoids more dangerous than regular cannabis?
This review noted synthetic cannabinoids are stronger at cannabinoid receptors than natural cannabis. Since 2010, numerous emergency room visits and deaths have been attributed to synthetic cannabinoid products.
Read More on RethinkTHC
- THC-purity-potency-label-meaning
- dab-concentrate-addiction-withdrawal
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- healthiest-way-to-consume-cannabis
- how-cannabis-products-made-concentrates-edibles
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- sativa-vs-indica-difference-myth
- weed-potency-withdrawal
Cite This Study
https://rethinkthc.com/research/RTHC-00458APA
Vardakou, I; Pistos, C; Spiliopoulou, Ch. (2010). Spice drugs as a new trend: mode of action, identification and legislation.. Toxicology letters, 197(3), 157-62. https://doi.org/10.1016/j.toxlet.2010.06.002
MLA
Vardakou, I, et al. "Spice drugs as a new trend: mode of action, identification and legislation.." Toxicology letters, 2010. https://doi.org/10.1016/j.toxlet.2010.06.002
RethinkTHC
RethinkTHC Research Database. "Spice drugs as a new trend: mode of action, identification a..." RTHC-00458. Retrieved from https://rethinkthc.com/research/vardakou-2010-spice-drugs-as-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.